+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Constipation Treatment - Global Strategic Business Report

  • PDF Icon

    Report

  • 194 Pages
  • December 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5309905
The global market for Constipation Treatment was estimated at US$18.4 Billion in 2023 and is projected to reach US$27.5 Billion by 2030, growing at a CAGR of 5.9% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Global Constipation Treatment Market - Key Trends & Drivers Summarized

Why Is There Increasing Demand for Constipation Treatment Solutions?

The growing prevalence of gastrointestinal disorders, particularly constipation, is driving demand for treatment solutions globally. Factors such as aging populations, sedentary lifestyles, poor dietary habits, and increasing levels of stress contribute to rising incidences of constipation, especially in developed regions. Moreover, constipation is a common side effect of medications used to treat chronic conditions like pain, hypertension, and diabetes. This has led to an increasing need for effective over-the-counter (OTC) laxatives, prescription medications, and natural remedies to alleviate symptoms and improve patients' quality of life.

How Are Technological and Pharmaceutical Innovations Impacting Constipation Treatment?

Pharmaceutical companies are continuously innovating to develop more effective and patient-friendly treatment options for constipation. Recent advancements include the development of novel laxatives with fewer side effects, such as osmotic laxatives, as well as medications like prokinetics that stimulate intestinal motility. Additionally, the rise of probiotics and fiber supplements as natural alternatives for managing constipation is gaining popularity, particularly among health-conscious consumers. Innovations in drug delivery mechanisms, such as extended-release formulations, are also helping to enhance treatment efficacy and patient compliance.

Which Demographic Segments Are Leading the Demand for Constipation Treatment?

The elderly population is a significant driver of demand for constipation treatments, as aging often leads to slower digestive function and increased reliance on medications that may cause constipation. Additionally, patients with chronic illnesses, such as irritable bowel syndrome (IBS), are frequent consumers of constipation treatment products. The increasing awareness of gastrointestinal health among younger populations is also fueling demand for OTC laxatives, natural remedies, and dietary supplements. Healthcare professionals are increasingly recommending preventive measures, including lifestyle modifications, to address chronic constipation, further driving the use of treatment solutions.

What Are the Key Growth Drivers of the Constipation Treatment Market?

The growth in the constipation treatment market is driven by several factors, including the increasing prevalence of gastrointestinal disorders, the growing aging population, and the rise in demand for OTC medications. The expanding awareness of digestive health and the rising trend toward self-medication are also boosting the demand for natural and OTC treatment options. Pharmaceutical advancements, such as the development of novel drugs with fewer side effects and more targeted action, are further contributing to market growth. Additionally, the increasing focus on preventive healthcare and lifestyle management is driving the adoption of dietary supplements and probiotics.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Laxatives segment, which is expected to reach US$12.3 Billion by 2030 with a CAGR of a 6.4%. The Chloride Channel Activators segment is also set to grow at 4.4% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, estimated at $4.9 Billion in 2023, and China, forecasted to grow at an impressive 8.9% CAGR to reach $6.4 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Constipation Treatment Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Constipation Treatment Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Constipation Treatment Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of major players in the Global Constipation Treatment Market such as Abbott, AbbVie's Inc., Albireo Pharma, Inc., AstraZeneca, Bausch Health Companies Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 41 companies featured in this Global Constipation Treatment market report include:

  • Abbott
  • AbbVie's Inc.
  • Albireo Pharma, Inc.
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cosmo Pharma
  • Daewoong
  • Ironwood Pharmaceuticals
  • Janssen Pharmaceutical
  • Mallinckrodt Plc
  • Prestige Brands
  • Renexxion
  • Sanofi
  • Shionogi
  • Takeda Pharmaceutical Company Limited

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of COVID-19 and a Looming Global Recession
  • Constipation Treatment - Global Key Competitors Percentage Market Share in 2024 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Growing Prevalence of Gastrointestinal Disorders
  • Increasing Demand for Over-the-counter Laxatives and Natural Remedies
  • Technological Advancements in Prescription Medications
  • Rising Use of Probiotics and Fiber Supplements in Constipation Management
  • Expanding Geriatric Population Driving Demand for Treatment Solutions
  • Growing Awareness of Digestive Health and Preventive Care
  • Increased Adoption of Combination Therapies for Chronic Conditions
  • Rise in Demand for Home-based Constipation Treatment Products
  • Rising Focus on Gut Health and Holistic Treatment Approaches
  • Growing Popularity of Personalized Medicine in Constipation Treatment
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Constipation Treatment Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Constipation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 3: World Historic Review for Constipation Treatment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 4: World 16-Year Perspective for Constipation Treatment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Laxatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 6: World Historic Review for Laxatives by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 7: World 16-Year Perspective for Laxatives by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Chloride Channel Activators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 9: World Historic Review for Chloride Channel Activators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 10: World 16-Year Perspective for Chloride Channel Activators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Peripherally Acting Mu-Opioid Receptor Antagonists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 12: World Historic Review for Peripherally Acting Mu-Opioid Receptor Antagonists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 13: World 16-Year Perspective for Peripherally Acting Mu-Opioid Receptor Antagonists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for GC-C Agonists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 15: World Historic Review for GC-C Agonists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 16: World 16-Year Perspective for GC-C Agonists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for 5-HT4 Receptor Agonists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 18: World Historic Review for 5-HT4 Receptor Agonists by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 19: World 16-Year Perspective for 5-HT4 Receptor Agonists by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Chronic Idiopathic Constipation (CIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 21: World Historic Review for Chronic Idiopathic Constipation (CIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 22: World 16-Year Perspective for Chronic Idiopathic Constipation (CIC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Irritable Bowel Syndrome with Constipation (IBS-C) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 24: World Historic Review for Irritable Bowel Syndrome with Constipation (IBS-C) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 25: World 16-Year Perspective for Irritable Bowel Syndrome with Constipation (IBS-C) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Opioid-Induced Constipation (OIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
  • Table 27: World Historic Review for Opioid-Induced Constipation (OIC) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
  • Table 28: World 16-Year Perspective for Opioid-Induced Constipation (OIC) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
CANADA
JAPAN
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
CHINA
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
EUROPE
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
FRANCE
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
GERMANY
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
ITALY
UNITED KINGDOM
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
AUSTRALIA
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
INDIA
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Constipation Treatment Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
IV. COMPETITION

Companies Mentioned

Some of the 41 companies featured in this Global Constipation Treatment market report include:
  • Abbott
  • AbbVie's Inc.
  • Albireo Pharma, Inc.
  • AstraZeneca
  • Bausch Health Companies Inc.
  • Bayer AG
  • Cosmo Pharma
  • Daewoong
  • Ironwood Pharmaceuticals
  • Janssen Pharmaceutical
  • Mallinckrodt Plc
  • Prestige Brands
  • Renexxion
  • Sanofi
  • Shionogi
  • Takeda Pharmaceutical Company Limited

Table Information